Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 280 articles:
HTML format



Single Articles


    December 2021
  1. CHAPMAN TP, Reves J, Torres J, Satsangi J, et al
    Anti-SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
    Gastroenterology. 2021;161:2057-2059.
    PubMed    


    November 2021
  2. DI NARZO AF, Houten SM, Kosoy R, Huang R, et al
    Integrative analysis of the Inflammatory Bowel Disease serum metabolome improves our understanding of genetic etiology and points to novel putative therapeutic targets.
    Gastroenterology. 2021 Nov 12. pii: S0016-5085(21)03738.
    PubMed     Abstract available


  3. BOLTON C, Smillie CS, Pandey S, Elmentaite R, et al
    An integrated taxonomy for monogenic inflammatory bowel disease.
    Gastroenterology. 2021 Nov 12. pii: S0016-5085(21)03737.
    PubMed     Abstract available


    October 2021
  4. SHAH SC, Itzkowitz SH
    Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.
    Gastroenterology. 2021 Oct 29. pii: S0016-5085(21)03707.
    PubMed    


  5. BEN-HORIN S, Novack L, Mao R, Guo J, et al
    Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease: A systematic review and an individual-patient data meta-analysis of randomized controlled trials.
    Gastroenterology. 2021 Oct 29. pii: S0016-5085(21)03709.
    PubMed     Abstract available


  6. SPIERA E, Agrawal M, Ungaro R
    COVID-19 mRNA Vaccine Short-Term Safety in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2021 Oct 6. pii: S0016-5085(21)03619.
    PubMed    


  7. KAPPELMAN MD, Weaver KN, Boccieri M, Firestine A, et al
    Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2021;161:1340-1343.
    PubMed    


  8. LIMA S, Gogokhia L, Viladomiu M, Chou L, et al
    Transferable IgA-coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
    Gastroenterology. 2021 Oct 1. pii: S0016-5085(21)03610.
    PubMed     Abstract available


    September 2021
  9. CLEVELAND NK, Rai V, El Jurdi K, Rao SS, et al
    ULCERATIVE COLITIS PATIENTS HAVE REDUCED RECTAL COMPLIANCE COMPARED WITH NON-IBD CONTROLS.
    Gastroenterology. 2021 Sep 28. pii: S0016-5085(21)03564.
    PubMed    


  10. SUGIMOTO S, Iwao Y, Shimoda M, Takabayashi K, et al
    Epithelium Replacement Contributes to Field Expansion of Squamous Epithelium and Ulcerative Colitis-Associated Neoplasia.
    Gastroenterology. 2021 Sep 28. pii: S0016-5085(21)03563.
    PubMed    


  11. COHEN NA, Silfen A, Rubin DT
    Inclusion of Under-Represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease.
    Gastroenterology. 2021 Sep 22. pii: S0016-5085(21)03535.
    PubMed    


  12. KHANNA R, Wilson AS, Gregor JC, Prowse KL, et al
    Clinical Guidelines for the Management of Inflammatory Bowel Disease.
    Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03521.
    PubMed    


  13. PANES J
    Integrin inhibitors in inflammatory bowel disease: from therapeutic antibodies to small molecule drugs.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03495.
    PubMed    


  14. KONDO A, Ma S, Lee MYY, Ortiz V, et al
    Highly multiplexed image analysis of intestinal tissue sections in patients with inflammatory bowel disease.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03480.
    PubMed     Abstract available


  15. UNGARO RC, Brenner EJ, Agrawal M, Zhang X, et al
    Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03490.
    PubMed    


  16. ALLIN KH, Moayyedi P
    Proton pump inhibitor use - a risk factor for inflammatory bowel disease or an innocent bystander?
    Gastroenterology. 2021 Sep 6. pii: S0016-5085(21)03478.
    PubMed    


  17. VAN DE GUCHTE M, Mondot S, Dore J
    Dynamic properties of the intestinal ecosystem call for combination therapies, targeting inflammation and microbiota, in ulcerative colitis.
    Gastroenterology. 2021 Sep 6. pii: S0016-5085(21)03482.
    PubMed     Abstract available


  18. ARGMANN C, Tokuyama M, Ungaro RC, Huang R, et al
    Molecular characterization of limited ulcerative colitis reveals novel biology and predictors of disease extension.
    Gastroenterology. 2021 Sep 1. pii: S0016-5085(21)03472.
    PubMed     Abstract available


    August 2021
  19. SANDBORN W, Mattheakis LC, Modi NB, Pugatch D, et al
    PTG-100, an Oral alpha4beta7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis.
    Gastroenterology. 2021 Aug 30. pii: S0016-5085(21)03463.
    PubMed     Abstract available


  20. BARBERIO B, Massimi D, Cazzagon N, Zingone F, et al
    Prevalence of Primary Sclerosing Cholangitis in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03412.
    PubMed     Abstract available


  21. POZDNYAKOVA V, Botwin GJ, Sobhani K, Prostko J, et al
    Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03360.
    PubMed    


  22. KUWADA T, Shiokawa M, Seno H
    Two novel autoantibodies in patients with ulcerative colitis.
    Gastroenterology. 2021 Aug 10. pii: S0016-5085(21)03354.
    PubMed    


  23. XIA B, Yang M, Nguyen LH, He Q, et al
    Regular use of proton pump inhibitor and the risk of inflammatory bowel disease: pooled analysis of three prospective cohorts.
    Gastroenterology. 2021 Aug 10. pii: S0016-5085(21)03350.
    PubMed     Abstract available


  24. ROGLER G, Singh A, Kavanaugh A, Rubin DT, et al
    Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
    Gastroenterology. 2021 Aug 3. pii: S0016-5085(21)03337.
    PubMed     Abstract available


  25. JONES JL, Tse F, Carroll MW, deBruyn JC, et al
    Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
    Gastroenterology. 2021;161:681-700.
    PubMed     Abstract available


  26. WONG SY, Dixon R, Martinez Pazos V, Gnjatic S, et al
    Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies.
    Gastroenterology. 2021;161:715-718.
    PubMed    


    July 2021
  27. BERGEMALM D, Andersson E, Hultdin J, Eriksson C, et al
    Systemic inflammation in pre-clinical ulcerative colitis.
    Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03277.
    PubMed     Abstract available


  28. MEDERACKE I, Wiestler M, Wedemeyer H
    An unusual cause of erythema on both lower legs in a patient with Crohn s disease.
    Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03249.
    PubMed    


  29. LECHNER K, Mott S, Al-Saifi R, Knipfer L, et al
    Targeting of the Tec kinase ITK drives resolution of T cell-mediated colitis and emerges as potential therapeutic option in ulcerative colitis.
    Gastroenterology. 2021 Jul 3. pii: S0016-5085(21)03186.
    PubMed     Abstract available


  30. BEN-TOV A, Banon T, Chodick G, Kariv R, et al
    BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.
    Gastroenterology. 2021 Jul 2. pii: S0016-5085(21)03233.
    PubMed    


  31. PAPA A, Gasbarrini A, Lopetuso LR
    Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients.
    Gastroenterology. 2021;161:368-369.
    PubMed    


  32. RODRIGUEZ-PALACIOS A, Basson AR, Cominelli F
    Artificial Sweeteners and Whole-Food Science: Could Mice Help Clinicians Make Diet Recommendations for IBD Patients?
    Gastroenterology. 2021;161:8-14.
    PubMed    


  33. DE A, Chen W, Li H, Wright JR, et al
    Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.
    Gastroenterology. 2021;161:211-224.
    PubMed     Abstract available


    June 2021
  34. REINISCH W
    PEG and mucosal biofilms in irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03167.
    PubMed    


  35. BAUMGARTNER M, Lang M, Holley H, Crepaz D, et al
    Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 16. pii: S0016-5085(21)03138.
    PubMed     Abstract available


  36. PEYRIN-BIROULET L, Loftus EV Jr, Colombel JF, Danese S, et al
    Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY.
    Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03126.
    PubMed     Abstract available


  37. HADI YB, Thakkar S, Shah-Khan SM, Hutson W, et al
    COVID-19 vaccination is safe and effective in patients with inflammatory bowel disease: Analysis of a large multi-institutional research network in United States.
    Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03125.
    PubMed    


  38. MAHMUD N, Weiss A, Trivedi C, Yang YX, et al
    Risk of Venous Thromboembolism among Inflammatory Bowel Disease patients who contract SARS-CoV-2.
    Gastroenterology. 2021 Jun 14. pii: S0016-5085(21)03123.
    PubMed    


  39. NARULA N, Wong ECL, Dehghan M, Marshall JK, et al
    BRIEF COMMUNICATION: Does High Inflammatory Diet Increase Risk of Inflammatory Bowel Disease? Results from the Prospective Urban Rural Epidemiology (PURE) study: A Prospective Cohort Study.
    Gastroenterology. 2021 Jun 9. pii: S0016-5085(21)03096.
    PubMed    


  40. BARBERIO B, Buda A, Savarino EV
    Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
    Gastroenterology. 2021;160:2626-2627.
    PubMed    


  41. BEZZIO C, Saibeni S
    Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist.
    Gastroenterology. 2021;160:2625-2626.
    PubMed    


  42. MAGO S, Vaziri H, Tadros M
    The Usefulness of Fecal Calprotectin in the era of the COVID-19 Pandemic.
    Gastroenterology. 2021;160:2623-2625.
    PubMed    


    May 2021
  43. KHAN N, Mahmud N
    Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03066.
    PubMed     Abstract available


  44. PAI N, Popov J, Hill L, Hartung E, et al
    Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects.
    Gastroenterology. 2021 May 4. pii: S0016-5085(21)00739.
    PubMed    


  45. STALGIS C, Deepak P, Mehandru S, Colombel JF, et al
    Rational Combination Therapy to Overcome the Plateau of Drug Efficacy in Inflammatory Bowel Disease.
    Gastroenterology. 2021 May 4. pii: S0016-5085(21)00740.
    PubMed    


  46. OCCHIPINTI V, Saibeni S, Sampietro GM, Pastorelli L, et al
    Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD: A Domino Effect.
    Gastroenterology. 2021;160:2196-2197.
    PubMed    


  47. SAHA S, Mara K, Pardi DS, Khanna S, et al
    Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Gastroenterology. 2021;160:1961-1969.
    PubMed     Abstract available


    April 2021
  48. AGRAWAL M, Spencer EA, Colombel JF, Ungaro RC, et al
    Approach to the management of recently diagnosed inflammatory bowel disease patients: a user's guide for adult and pediatric gastroenterologists.
    Gastroenterology. 2021 Apr 30. pii: S0016-5085(21)00734.
    PubMed     Abstract available


  49. RAJAMAKI K, Taira A, Katainen R, Valimaki N, et al
    Genetic and epigenetic characteristics of inflammatory bowel disease associated colorectal cancer.
    Gastroenterology. 2021 Apr 27. pii: S0016-5085(21)00680.
    PubMed     Abstract available


  50. AGRAWAL M, Hillenbrand CM, Allin KH, Torres J, et al
    Early life greenspace and the risk of pediatric-onset inflammatory bowel disease: insights into the link between environmental and human health.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00644.
    PubMed    


  51. TAXONERA C, Alba C, Olivares D
    What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?
    Gastroenterology. 2021;160:1901-1902.
    PubMed    


  52. MAGRO F, Dias CC, Morato M
    Aminosalicylates and COVID-19: Facts or Coincidences?
    Gastroenterology. 2021;160:1884-1885.
    PubMed    


  53. RODRIGUEZ-LAGO I, Alonso-Galan H, Cabriada JL
    Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy.
    Gastroenterology. 2021;160:1878-1880.
    PubMed    


  54. RABINOWITZ LG, Kim MK, Wong SY
    Farnesoid X Receptor Variant: A Sex-based Determinant of Crohn's Disease Progression.
    Gastroenterology. 2021;160:1866-1867.
    PubMed    


  55. SHORT SP, Pilat JM, Barrett CW, Reddy VK, et al
    Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.
    Gastroenterology. 2021;160:1694-1708.
    PubMed     Abstract available


  56. GETTLER K, Levantovsky R, Moscati A, Giri M, et al
    Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort.
    Gastroenterology. 2021;160:1546-1557.
    PubMed     Abstract available


  57. QU JY, Li Z
    Is It a Crohn's Disease?
    Gastroenterology. 2021;160:1477-1478.
    PubMed    


    March 2021
  58. SOLITANO V, Vuitton L, Peyrin-Biroulet L, Danese S, et al
    The Evolution of Biologics Administration From Intravenous to Subcutaneous: Treatments for Inflammatory Bowel Disease Goes Home.
    Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00548.
    PubMed    


  59. SHIRAI T, Kakuta Y, Fujii H
    Distinct autoantibodies against endothelial protein C receptor in ulcerative colitis.
    Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00547.
    PubMed    


  60. UNGER LW, Kaser A
    Is IL-6 back in trans signalling for inflammatory bowel disease?
    Gastroenterology. 2021 Mar 19. pii: S0016-5085(21)00539.
    PubMed    


  61. SCHREIBER S, Ben-Horin S, Leszczyszyn J, Dudkowiak R, et al
    Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease.
    Gastroenterology. 2021 Mar 4. pii: S0016-5085(21)00474.
    PubMed     Abstract available


  62. SCHREIBER S, Aden K, Bernardes JP, Conrad C, et al
    Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease.
    Gastroenterology. 2021 Mar 2. pii: S0016-5085(21)00467.
    PubMed     Abstract available


  63. VERMEIRE S, Hebuterne X, Tilg H, De Hertogh G, et al
    Induction and long-term follow-up with ABX464 for moderate-to-severe ulcerative colitis: Results of phase 2a trial.
    Gastroenterology. 2021 Mar 1. pii: S0016-5085(21)00459.
    PubMed    


  64. ILIEV ID, Cadwell K
    Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:1050-1066.
    PubMed     Abstract available


  65. LU R, Zhang YG, Xia Y, Zhang J, et al
    Paneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors.
    Gastroenterology. 2021;160:1269-1283.
    PubMed     Abstract available


  66. KUMAR A, Priyamvada S, Ge Y, Jayawardena D, et al
    A Novel Role of SLC26A3 in the Maintenance of Intestinal Epithelial Barrier Integrity.
    Gastroenterology. 2021;160:1240-1255.
    PubMed     Abstract available


  67. AL-BAHLANI AQ, Kron CM, Hart L
    Chronic Diarrhea in a Pediatric Patient after Bone Marrow Transplantation.
    Gastroenterology. 2021;160:e10-e12.
    PubMed    


    February 2021
  68. BENCHIMOL EI, Tse F, Carroll MW, deBruyn JC, et al
    TEMPORARY REMOVAL: Canadian Association of Gastroenterology CLINICAL Practice Guideline For Immunizations in Patients with Inflammatory Bowel Disease (IBD). Part 2: Inactivated Vaccines.
    Gastroenterology. 2021 Feb 19. pii: S0016-5085(21)00427.
    PubMed     Abstract available


  69. MA C, Sedano R, Almradi A, Casteele NV, et al
    An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials.
    Gastroenterology. 2021 Feb 18. pii: S0016-5085(21)00423.
    PubMed     Abstract available


  70. KUWADA T, Shiokawa M, Kodama Y, Ota S, et al
    Identification of an Anti-Integrin alphavbeta6 Autoantibody in Patients with Ulcerative Colitis.
    Gastroenterology. 2021 Feb 11. pii: S0016-5085(21)00406.
    PubMed     Abstract available


  71. COHEN RD, Feuerstein JD, Rubin DT
    REPLY to letters to the editor regarding manuscript Rubin DT, Feuerstein JD, Wang AY, Cohen RD, AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary, Gastroenterology (2020).
    Gastroenterology. 2021 Feb 6. pii: S0016-5085(21)00399.
    PubMed    


  72. NOWAK JK, Kalla R, Satsangi J
    SARS-CoV-2 entry molecules' expression and COVID-19 in inflammatory bowel disease: is the gut critical?
    Gastroenterology. 2021 Feb 4. pii: S0016-5085(21)00350.
    PubMed    


  73. KHANNA R, Afif W
    Ustekinumab for Ulcerative colitis.
    Gastroenterology. 2021 Feb 3. pii: S0016-5085(21)00340.
    PubMed    


  74. POTDAR AA, Dube S, Naito T, Li K, et al
    Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
    Gastroenterology. 2021;160:809-822.
    PubMed     Abstract available


  75. TE GROEN M, Derks MEW, Kuijpers CCHJ, Nagtegaal ID, et al
    Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study.
    Gastroenterology. 2021;160:935-937.
    PubMed    


  76. PATANKAR JV, Chiriac MT, Lehmann M, Kuhl AA, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling.
    Gastroenterology. 2021;160:925-928.
    PubMed    


  77. MELMED GY, Rubin DT, McGovern DPB
    Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
    Gastroenterology. 2021;160:639-644.
    PubMed    


  78. BURGUENO JF, Fritsch J, Gonzalez EE, Landau KS, et al
    Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
    Gastroenterology. 2021;160:797-808.
    PubMed     Abstract available


  79. BARNES EL, Loftus EV Jr, Kappelman MD
    Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:677-689.
    PubMed     Abstract available


  80. CHUNG-YEE HUI R, Kuo KL, Yang TW
    A Rare Skin Complication Associated With Crohn's Disease.
    Gastroenterology. 2021;160:669-670.
    PubMed    


  81. KUMAR A, Magro C, Lukin DJ
    Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease.
    Gastroenterology. 2021;160:e3-e5.
    PubMed    


    January 2021
  82. ZILBAUER M, Heuschkel R
    Reply to Lee et al.: Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
    Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00317.
    PubMed    


  83. MESERVE J, Singh S
    Pathologist, meet Picasso! Virtual chromoendoscopy for detecting histologic remission in ulcerative colitis.
    Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00318.
    PubMed    


  84. TAKENAKA K, Ohtsuka K, Fujii T, Oshima S, et al
    Deep neural network accurately predicts prognosis of ulcerative colitis using endoscopic images.
    Gastroenterology. 2021 Jan 21. pii: S0016-5085(21)00278.
    PubMed    


  85. RANDOLPH GJ, Czepielewski RS
    Response to: Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00270.
    PubMed    


  86. PINTO-SANCHEZ MI, Seiler C, Verdu EF
    Reply to: Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00273.
    PubMed    


  87. BRAND EC, Klaassen MAY, Gacesa R, Vila AV, et al
    Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients.
    Gastroenterology. 2021 Jan 18. pii: S0016-5085(21)00097.
    PubMed     Abstract available


  88. BHAT S, Farraye FA, Hayney MS, Caldera F, et al
    How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease.
    Gastroenterology. 2021 Jan 15. pii: S0016-5085(21)00093.
    PubMed    


  89. KHAN N, Yang YX
    Adherence of Infusible Biologics During the Time of COVID-19 Among Patients with Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study.
    Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00071.
    PubMed    


  90. LEE JC, Lyons PA, McKinney EF
    Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
    Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00081.
    PubMed    


  91. LE BERRE C, Peyrin-Biroulet L
    Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00016.
    PubMed     Abstract available


  92. CHEN E, Chuang LS, Giri M, Villaverde N, et al
    Inflamed ulcerative colitis regions associated to MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00024.
    PubMed     Abstract available


  93. SUAREZ-FARINAS M, Tokuyama M, Wei G, Huang R, et al
    Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.
    Gastroenterology. 2021;160:287-301.
    PubMed     Abstract available


  94. LEE M, Chang EB
    Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Gastroenterology. 2021;160:524-537.
    PubMed     Abstract available


  95. KELLERMAYER R, van der Laan M
    Validation of Predictive Models in Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:21-22.
    PubMed    


  96. NORSA L, D'Antiga L
    Reply.
    Gastroenterology. 2021;160:474-475.
    PubMed    


  97. SAZONOVS A, Ahmad T, Anderson CA
    Underpowered PANTS: A Response to the Conclusions of "Extended Analysis Identifies Drug-Specific Association of Two Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab".
    Gastroenterology. 2021;160:470-471.
    PubMed    


  98. CASADEI C, Barberio B, Savarino E
    A Peculiar Cutaneous Manifestation in a Patient With Crohn's Disease.
    Gastroenterology. 2021;160:e1-e3.
    PubMed    


  99. ZHANG J, Hoedt EC, Liu Q, Berendsen E, et al
    Elucidation of Proteus mirabilis as a Key Bacterium in Crohn's Disease Inflammation.
    Gastroenterology. 2021;160:317-330.
    PubMed     Abstract available


  100. RICCIUTO A, Aardoom M, Orlanski-Meyer E, Navon D, et al
    Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.
    Gastroenterology. 2021;160:403-436.
    PubMed     Abstract available


    December 2020
  101. UNGARO RC, Kappelman MD, Rubin DT, Colombel JF, et al
    COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions.
    Gastroenterology. 2020 Dec 30. pii: S0016-5085(20)35600.
    PubMed    


  102. TIAN Y, Zuo L
    Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35599.
    PubMed    


  103. TSE CS, Deepak P, Papadakis K
    Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35594.
    PubMed    


  104. WIJNANDS AM, de Jong ME, Lutgens MWMD, Hoentjen F, et al
    Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35587.
    PubMed     Abstract available


  105. SHIMIZU MS, Matsuo T, Mori N
    A rare manifestation associated with a urinary tract infection in a patient with ulcerative colitis.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35566.
    PubMed    


  106. TURNER D, Ricciuto A, Lewis A, D'Amico F, et al
    STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35572.
    PubMed     Abstract available


  107. DEVLIN JC, Axelrad J, Hine AM, Chang S, et al
    Single Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells from Ulcerative Colitis Patients.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35571.
    PubMed     Abstract available


  108. IACUCCI M, Smith SC, Bazarova A, Shivaji UN, et al
    An international multicenter real-life prospective study of electronic chromoendoscopy score PICaSSO in Ulcerative Colitis.
    Gastroenterology. 2020 Dec 18. pii: S0016-5085(20)35563.
    PubMed     Abstract available


  109. WAUTERS L, Ceulemans M, Frings D, Lambaerts M, et al
    Proton pump inhibitors reduce duodenal eosinophilia, mast cells and permeability in patients with functional dyspepsia.
    Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35552.
    PubMed     Abstract available


  110. KIM ES, Tarassishin L, Eisele C, Barre A, et al
    Longitudinal Changes in Fecal Calprotectin Levels among Pregnant Women with and without Inflammatory Bowel Disease and Their Babies.
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35532.
    PubMed     Abstract available


  111. VERSTOCKT B, Torres J
    Point-of-care intestinal ultrasound: prime time for the management of ulcerative colitis?
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35541.
    PubMed    


  112. GALIPEAU HJ, Caminero A, Turpin W, Bermudez-Brito M, et al
    Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis.
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35533.
    PubMed     Abstract available


  113. ROSEN MJ
    Could a Small Population of Epithelial Cells Get "Tuft" With Crohn's Disease?
    Gastroenterology. 2020;159:2025-2027.
    PubMed    


  114. KONG L, Lloyd-Price J, Vatanen T, Seksik P, et al
    Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
    Gastroenterology. 2020;159:2193-2202.
    PubMed     Abstract available


  115. BANERJEE A, Herring CA, Chen B, Kim H, et al
    Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal Inflammation.
    Gastroenterology. 2020;159:2101-2115.
    PubMed     Abstract available


  116. TURPIN W, Lee SH, Raygoza Garay JA, Madsen KL, et al
    Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.
    Gastroenterology. 2020;159:2092-2100.
    PubMed     Abstract available


  117. COURTET A, Lemale J, Carra MC
    Generalized Gingival Hyperplasia and Rectorrhagia in a 13-Year-Old Boy.
    Gastroenterology. 2020;159:2030-2033.
    PubMed    


  118. ANGELINO G, Francalanci P, Tambucci R
    Terminal Ileum Thickening and Mucosal Ulcers in a Boy With Neurofibromatosis Type 1.
    Gastroenterology. 2020;159:e9-e11.
    PubMed    


    November 2020
  119. MAHADEVAN U, Long MD, Kane SV, Roy A, et al
    Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Nov 20. pii: S0016-5085(20)35441.
    PubMed     Abstract available


  120. TAXONERA C, Fisac J, Alba C
    Can COVID-19 trigger de novo inflammatory bowel disease?
    Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35424.
    PubMed    


  121. FAIRBRASS KM, Gracie DJ, Ford AC
    In the Face of Adversity: Is Resilience Training a New Target for Inflammatory Bowel Disease Therapy?
    Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35417.
    PubMed    


  122. TORRES J, Riddle M, Colombel JF
    Answer to the letter by Rodriguez-Lago et al: Pre-inflammatory bowel disease: back to the future.
    Gastroenterology. 2020 Nov 4. pii: S0016-5085(20)35363.
    PubMed    


  123. KOCHAR B, Ananthakrishnan AN
    Reply.
    Gastroenterology. 2020;159:1993-1994.
    PubMed    


  124. ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
    Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.
    Gastroenterology. 2020;159:1982-1984.
    PubMed    


  125. PARLATO M, Nian Q, Charbit-Henrion F, Ruemmele FM, et al
    Loss-of-Function Mutation in PTPN2 Causes Aberrant Activation of JAK Signaling Via STAT and Very Early Onset Intestinal Inflammation.
    Gastroenterology. 2020;159:1968-1971.
    PubMed    


  126. HUANG LH, Deepak P, Ciorba MA, Mittendorfer B, et al
    Postprandial Chylomicron Output and Transport Through Intestinal Lymphatics Are Not Impaired in Active Crohn's Disease.
    Gastroenterology. 2020;159:1955-1957.
    PubMed    


  127. SPALINGER MR, Sayoc-Becerra A, Santos AN, Shawki A, et al
    PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function.
    Gastroenterology. 2020;159:1763-1777.
    PubMed     Abstract available


    October 2020
  128. NAITO T, Botwin GJ, Haritunians T, Li D, et al
    Prevalence and Effect of Genetic Risk of Thrombo-embolic Disease in Inflammatory Bowel Disease.
    Gastroenterology. 2020 Oct 19. pii: S0016-5085(20)35276.
    PubMed     Abstract available


  129. GOTTLIEB K, Requa J, Karnes W, Chandra Gudivada R, et al
    Central reading of ulcerative colitis clinical trial videos using neural networks.
    Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35283.
    PubMed     Abstract available


  130. BOSSUYT P, De Hertogh G, Eelbode T, Vermeire S, et al
    Computer aided diagnosis with monochromatic light endoscopy for scoring histological remission in ulcerative colitis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35246.
    PubMed    


  131. ANANTHAKRISHNAN AN, Nguyen GC, Bernstein CN
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in the Elderly: Expert Review.
    Gastroenterology. 2020 Oct 1. pii: S0016-5085(20)35219.
    PubMed    


  132. GARG M, Christensen B, Lubel JS
    Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?
    Gastroenterology. 2020;159:1623-1624.
    PubMed    


  133. PARIGI TL, Bonifacio C, Danese S
    Is It Crohn's Disease?
    Gastroenterology. 2020;159:1244-1246.
    PubMed    


  134. TAKENAKA K, Ohtsuka K, Suzuki K, Watanabe M, et al
    Reply.
    Gastroenterology. 2020;159:1626-1627.
    PubMed    


  135. GORDON M, Guyatt G
    Assessment of Evidence Quality in Inflammatory Bowel Disease Guidance: The Use and Misuse of GRADE.
    Gastroenterology. 2020;159:1209-1215.
    PubMed    


  136. STENGEL ST, Fazio A, Lipinski S, Jahn MT, et al
    Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.
    Gastroenterology. 2020;159:1357-1374.
    PubMed     Abstract available


  137. RAWAT M, Nighot M, Al-Sadi R, Gupta Y, et al
    IL1B Increases Intestinal Tight Junction Permeability by Up-regulation of MIR200C-3p, Which Degrades Occludin mRNA.
    Gastroenterology. 2020;159:1375-1389.
    PubMed     Abstract available


    September 2020
  138. KELLY CR, Yen EF, Grinspan AM, Kahn SA, et al
    Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry.
    Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35221.
    PubMed     Abstract available


  139. MEYER EO, Aardoom M, Ricciuto A, Navon D, et al
    Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements from PIBD-Ahead Program.
    Gastroenterology. 2020 Sep 22. pii: S0016-5085(20)35206.
    PubMed     Abstract available


  140. ABREU MT, Sandborn WJ
    Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design.
    Gastroenterology. 2020 Sep 19. pii: S0016-5085(20)35168.
    PubMed    


  141. RODRIGUEZ-LAGO I, Marigorta UM, Acosta MB
    Preclinical inflammatory bowel disease: back to the future.
    Gastroenterology. 2020 Sep 12. pii: S0016-5085(20)35152.
    PubMed    


  142. PAUL S, Roblin X
    The Nightmare Monitoring of JAKinhibs.
    Gastroenterology. 2020;159:1188-1189.
    PubMed    


  143. TILG H, D'Haens G
    How to Manage Crohn's Disease After Ileocolonic Resection?
    Gastroenterology. 2020;159:816-820.
    PubMed    


  144. KANG JW, Yan J, Ranjan K, Zhang X, et al
    Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation.
    Gastroenterology. 2020;159:1051-1067.
    PubMed     Abstract available


  145. KREISS L, Thoma OM, Dilipkumar A, Carle B, et al
    Label-Free In Vivo Histopathology of Experimental Colitis via 3-Channel Multiphoton Endomicroscopy.
    Gastroenterology. 2020;159:832-834.
    PubMed    


  146. HALL CHT, Lee JS, Murphy EM, Gerich ME, et al
    Creatine Transporter, Reduced in Colon Tissues From Patients With Inflammatory Bowel Diseases, Regulates Energy Balance in Intestinal Epithelial Cells, Epithelial Integrity, and Barrier Function.
    Gastroenterology. 2020;159:984-998.
    PubMed     Abstract available


  147. PINTO-SANCHEZ MI, Seiler CL, Santesso N, Alaedini A, et al
    Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;159:884-903.
    PubMed     Abstract available


    August 2020
  148. NORSA L, Cosimo P, Indriolo A, Sansotta N, et al
    Asymptomatic SARS-CoV-2 infection in patients with inflammatory bowel disease under biologic treatment.
    Gastroenterology. 2020 Aug 26. pii: S0016-5085(20)35117.
    PubMed    


  149. LI K, Marano C, Zhang H, Yang F, et al
    Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
    Gastroenterology. 2020 Aug 24. pii: S0016-5085(20)35107.
    PubMed     Abstract available


  150. HERNDON JS, Vitta S, Weber FH Jr
    Marked Eosinophilia in a 27-Year-Old Woman with Recent Onset Ulcerative Colitis.
    Gastroenterology. 2020 Aug 20. pii: S0016-5085(20)35069.
    PubMed    


  151. GASPARETTO M, Payne F, Nayak K, Kraiczy J, et al
    Transcription and DNA Methylation patterns of blood derived CD8(+) T cells are associated with age and Inflammatory Bowel Disease but do not predict prognosis.
    Gastroenterology. 2020 Aug 16. pii: S0016-5085(20)35056.
    PubMed     Abstract available


  152. BOSSUYT P, Vermeire S, Bisschops R
    Assessing disease activity in ulcerative colitis using artificial intelligence: can "equally good" be seen as "better"?
    Gastroenterology. 2020 Aug 13. pii: S0016-5085(20)35044.
    PubMed    


  153. WALSHE M, Silverberg MS, Targownik LE
    What Constitutes Frailty In Inflammatory Bowel Disease?
    Gastroenterology. 2020 Aug 12. pii: S0016-5085(20)35045.
    PubMed    


  154. JANSSON-KNODELL CL, Walker MJ, Fischer M
    Pancytopenia in a Young Male Patient with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Aug 7. pii: S0016-5085(20)35027.
    PubMed    


  155. HENN MR, O'Brien EJ, Diao L, Feagan BG, et al
    A Phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis.
    Gastroenterology. 2020 Aug 4. pii: S0016-5085(20)35012.
    PubMed     Abstract available


  156. BRENNER EJ, Ungaro RC, Gearry RB, Kaplan GG, et al
    Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.
    Gastroenterology. 2020;159:481-491.
    PubMed     Abstract available


  157. STAHL E, Roda G, Dobbyn A, Hu J, et al
    Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases.
    Gastroenterology. 2020;159:549-561.
    PubMed     Abstract available


  158. POWELL DOHERTY RD, Liao H, Satsangi JJ, Ternette N, et al
    Extended Analysis Identifies Drug-Specific Association of 2 Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab.
    Gastroenterology. 2020;159:784-787.
    PubMed    


  159. APOSTOLOV R, Tan N, Vasudevan A
    Poor Bowel Preparation in Crohn's Disease.
    Gastroenterology. 2020;159:440-442.
    PubMed    


    July 2020
  160. BARBERIO B, Zingone F, Bertani L, Savarino E, et al
    The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients During COVID-19 Pandemic: Is It Really a Problem?
    Gastroenterology. 2020 Jul 17. pii: S0016-5085(20)34943.
    PubMed    


  161. KHANNA R, Zhou GY, Afif W
    Comparative Efficacy Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2020 Jul 15. pii: S0016-5085(20)34930.
    PubMed     Abstract available


  162. CAPPELLO M, Busacca A, Guida L
    The course of Covid 19 in Inflammatory Bowel Disease: protective role of TNF antagonists Response to: Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an
    Gastroenterology. 2020 Jul 6. pii: S0016-5085(20)34920.
    PubMed    


  163. MOCCIARO F, Scimeca D, Di Mitri R
    THE COURAGE TO RETURN TO EVERYDAY LIFE AT THE TIME OF COVID-19: THE POINT OF VIEW OF INFLAMMATORY BOWEL DISEASE PATIENTS NEEDING ENDOSCOPY.
    Gastroenterology. 2020 Jul 1. pii: S0016-5085(20)34913.
    PubMed    


  164. NORSA L, Indriolo A, Sansotta N, Cosimo P, et al
    Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy.
    Gastroenterology. 2020;159:371-372.
    PubMed    


  165. BERNSTEIN CN
    New Biomarkers for Crohn's Disease.
    Gastroenterology. 2020;159:30-32.
    PubMed    


  166. UNO Y
    Why a Low FODMAP Diet Was Ineffective for IBS Symptoms in Quiescent Crohn's Disease.
    Gastroenterology. 2020;159:399.
    PubMed    


  167. ARDALAN ZS, Sparrow M, Gibson PR
    The Importance of Accurate Phenotyping and Pouchitis Risk and Dietary Assessment When Investigating the Microbial Factors Behind Antibiotic-Dependent Pouchitis.
    Gastroenterology. 2020;159:399-400.
    PubMed    


  168. PICKERT G, Wirtz S, Matzner J, Ashfaq-Khan M, et al
    Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis.
    Gastroenterology. 2020;159:257-272.
    PubMed     Abstract available


  169. EL-MATARY W, Nugent Z, Bernstein CN, Singh H, et al
    Long-term Cancer Risk in Patients With Pediatric-Onset Inflammatory Bowel Diseases in the Canadian Population.
    Gastroenterology. 2020;159:386-387.
    PubMed    


  170. NAIR N, Austin C, Curtin P, Gouveia C, et al
    Association Between Early-life Exposures and Inflammatory Bowel Diseases, Based on Analyses of Deciduous Teeth.
    Gastroenterology. 2020;159:383-385.
    PubMed    


  171. UNGARO RC, Yzet C, Bossuyt P, Baert FJ, et al
    Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.
    Gastroenterology. 2020;159:139-147.
    PubMed     Abstract available


  172. MULLIN GE, Chey WD, Crowe SE
    The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease.
    Gastroenterology. 2020;159:20-25.
    PubMed    


  173. HEALY ME, Boege Y, Hodder MC, Bohm F, et al
    MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice.
    Gastroenterology. 2020;159:183-199.
    PubMed     Abstract available


  174. TORRES J, Petralia F, Sato T, Wang P, et al
    Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
    Gastroenterology. 2020;159:96-104.
    PubMed     Abstract available


    June 2020
  175. YOON H, Jangi S, Dulai PS, Boland BS, et al
    Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020 Jun 22. pii: S0016-5085(20)34844.
    PubMed     Abstract available


  176. KHAN N, Patel D, Xie D, Pernes T, et al
    Adherence of infusible biologics during the time of COVID-19 among patients with Inflammatory Bowel Disease: A nationwide VA cohort study.
    Gastroenterology. 2020 Jun 20. pii: S0016-5085(20)34845.
    PubMed    


  177. KJAERGAARD VS, Jensen CB, Elmahdi R, Burisch J, et al
    Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based Danish Cohort Study.
    Gastroenterology. 2020 Jun 18. pii: S0016-5085(20)34830.
    PubMed    


  178. BANGMA A, Voskuil MD, Weersma RK
    TNFalpha-antagonist use and mucosal inflammation are associated with increased intestinal expression of SARS-CoV-2 host protease TMPRSS2 in patients with inflammatory bowel disease.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34783.
    PubMed    


  179. BRAIN O, Satsangi J
    Therapeutic decisions in inflammatory bowel disease in the SARS-Cov-2 pandemic.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34775.
    PubMed    


  180. CHEN J, Peng X, Zhang M, Zhi M, et al
    Impact of medication discontinuation on patients with inflammatory bowel disease during the COVID-19 outbreak.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34779.
    PubMed    


  181. SINGH S, Khan A, Chowdhry M, Bilal M, et al
    Risk of Severe COVID-19 in Patients with Inflammatory Bowel Disease in United States. A Multicenter Research Network Study.
    Gastroenterology. 2020 Jun 6. pii: S0016-5085(20)34755.
    PubMed    


  182. RUETHER DF, Menz A, Manthey CF
    A Dishevelled Man with Inflammatory Bowel Disease and Signs of Infection.
    Gastroenterology. 2020 Jun 5. pii: S0016-5085(20)34749.
    PubMed    


  183. SABINO J, Torres J
    You Are What You Eat, But Can Diet Prevent Inflammatory Bowel Diseases?
    Gastroenterology. 2020;158:2304-2305.
    PubMed    


  184. ZIDAR N
    Histopathology of Fibrosis in Crohn's Disease: The Importance of Understanding Its Pathogenesis.
    Gastroenterology. 2020;158:2313-2314.
    PubMed    


  185. BOUHNIK Y, Louis E, Peyrin-Biroulet L
    Looking for Innovative Digital Solutions to Optimize Patient Recruitment in Inflammatory Bowel Disease Trials.
    Gastroenterology. 2020;158:2306-2307.
    PubMed    


  186. KOLLEN L, Werner O, Gavotto A
    Uncommon Cause of Chest Pain in a 9-Year-Old Boy With Crohn's Disease.
    Gastroenterology. 2020;158:2055-2057.
    PubMed    


  187. KOCHAR B, Cai W, Cagan A, Ananthakrishnan AN, et al
    Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2020;158:2104-2111.
    PubMed     Abstract available


  188. CROWLEY E, Warner N, Pan J, Khalouei S, et al
    Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center.
    Gastroenterology. 2020;158:2208-2220.
    PubMed     Abstract available


  189. SANDBORN WJ, Feagan BG, Loftus EV Jr, Peyrin-Biroulet L, et al
    Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
    Gastroenterology. 2020;158:2123-2138.
    PubMed     Abstract available


  190. LOEBENSTEIN M, Schulberg JD
    Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn's Disease.
    Gastroenterology. 2020;158:2069-2071.
    PubMed    


    May 2020
  191. LUKIN DJ, Kumar A, Hajifathalian K, Sharaiha RZ, et al
    Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2020 May 29. pii: S0016-5085(20)34738.
    PubMed    


  192. KHAN N, Patel D, Xie D, Lewis J, et al
    Impact of Anti-TNF and Thiopurines medications on the development of COVID-19 in patients with inflammatory bowel disease: A Nationwide VA cohort study.
    Gastroenterology. 2020 May 29. pii: S0016-5085(20)34737.
    PubMed    


  193. LEES CW, Regueiro M, Mahadevan U
    Innovation in IBD Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease.
    Gastroenterology. 2020 May 28. pii: S0016-5085(20)34735.
    PubMed    


  194. KALINE A, Bram V, Anabela SR, Severine V, et al
    Ex vivo mimicking of inflammation in organoids derived from patients with ulcerative colitis.
    Gastroenterology. 2020 May 28. pii: S0016-5085(20)34736.
    PubMed    


  195. TRIVEDI PJ, Crothers H, Mytton J, Bosch S, et al
    Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Diseases, Based on Sex, Race, and Age.
    Gastroenterology. 2020 May 20. pii: S0016-5085(20)34702.
    PubMed     Abstract available


  196. BHAT S, Farraye FA, Moss A
    Roles of Clinical Pharmacists in Caring for Patients with Inflammatory Bowel Disease during COVID-19.
    Gastroenterology. 2020 May 18. pii: S0016-5085(20)30677.
    PubMed    


  197. MITSIALIS V, Wall S, Liu P, Ordovas-Montanes J, et al
    Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Gastroenterology. 2020 May 16. pii: S0016-5085(20)30658.
    PubMed     Abstract available


  198. KOTZE PG, Peyrin-Biroulet L, Danese S
    Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic.
    Gastroenterology. 2020 May 15. pii: S0016-5085(20)30660.
    PubMed    


  199. KRZYSZTOF NJ, Christoffer LJ, Rahul K, Ricanek P, et al
    Age, inflammation and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease.
    Gastroenterology. 2020 May 12. pii: S0016-5085(20)30653.
    PubMed    


  200. MACALUSO FS, Orlando A
    Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19?
    Gastroenterology. 2020 May 11. pii: S0016-5085(20)30619.
    PubMed    


  201. LO CH, Lochhead P, Khalili H, Song M, et al
    Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative Colitis.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30603.
    PubMed     Abstract available


  202. GOWER-ROUSSEAU C, Fumery M, Pariente B
    Inflammatory bowel disease and the SARS-CoV-2 pandemic: more speed, less haste.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30605.
    PubMed    


  203. GUBATAN J, Levitte S, Balabanis T, Patel A, et al
    SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California.
    Gastroenterology. 2020 May 6. pii: S0016-5085(20)30601.
    PubMed    


  204. OLIVERA PA, Lasa JS, Bonovas S, Danese S, et al
    Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;158:1554-1573.
    PubMed     Abstract available


    April 2020
  205. D'AMICO F, Danese S, Peyrin-Biroulet L
    Inflammatory bowel disease management during the COVID-19 outbreak: a survey from the European Crohn's and Colitis Organization (ECCO).
    Gastroenterology. 2020 Apr 30. pii: S0016-5085(20)30578.
    PubMed    


  206. RODRIGUEZ-LAGO I, Ramirez de la Piscina P, Elorza A, Merino O, et al
    Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain).
    Gastroenterology. 2020 Apr 21. pii: S0016-5085(20)30560.
    PubMed    


  207. PARIGI TL, D'Amico F, Danese S
    Upadacitinib for Crohn's disease and ulcerative colitis treatment: hitting the selective JAKpot.
    Gastroenterology. 2020 Apr 17. pii: S0016-5085(20)30517.
    PubMed    


  208. HOLMER AK, Dulai PS
    Deep Learning Accurately Predicts Endoscopic and Histologic Remission in Ulcerative Colitis - What the Eye Doesn't See, the Artificial Mind Does Actually Know.
    Gastroenterology. 2020 Apr 11. pii: S0016-5085(20)30481.
    PubMed    


  209. RUBIN DT, Feuerstein JD, Wang AY, Cohen RD, et al
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
    Gastroenterology. 2020 Apr 10. pii: S0016-5085(20)30482.
    PubMed     Abstract available


  210. RUBIN DT, Abreu MT, Rai V, Siegel CA, et al
    Management of Patients with Crohn's Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting.
    Gastroenterology. 2020 Apr 6. pii: S0016-5085(20)30465.
    PubMed    


  211. FAYE AS, Colombel JF
    Age is Just a Number: How Frailty May Predict Outcomes Within Inflammatory Bowel Disease.
    Gastroenterology. 2020 Apr 2. pii: S0016-5085(20)30456.
    PubMed    



  212. Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.
    Gastroenterology. 2020;158:1462-1463.
    PubMed    


  213. ADEN K, Schreiber S, Rosenstiel P
    Reply.
    Gastroenterology. 2020;158:1512-1513.
    PubMed    


  214. CHEN J, Vitetta L
    Butyrate in Inflammatory Bowel Disease Therapy.
    Gastroenterology. 2020;158:1511.
    PubMed    


  215. JAZAYERI A, Nonga D, Rao M
    The Key to a Boy's Heart Is Through His Intestine.
    Gastroenterology. 2020;158:1226-1228.
    PubMed    


    March 2020
  216. BAMIAS G, Rivera-Nieves J, Mantzaris GJ
    Efficacy of IL12/23 blockade expands our therapeutic targets and challenges the old dogma in ulcerative colitis.
    Gastroenterology. 2020 Mar 18. pii: S0016-5085(20)30366.
    PubMed     Abstract available


  217. SPENCER EA, Helmus D, Telesco S, Colombel JF, et al
    Inflammatory Bowel Disease Clusters Within Affected Sibships in Ashkenazi Jewish Multiplex Families.
    Gastroenterology. 2020 Mar 18. pii: S0016-5085(20)30365.
    PubMed    


  218. FEUERSTEIN JD, Isaacs KL, Schneider Y, Siddique SM, et al
    Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.
    Gastroenterology. 2020 Mar 10. pii: S0016-5085(20)30333.
    PubMed    


  219. DANESE S, Rimola J, Siegelman J
    Reply.
    Gastroenterology. 2020;158:1177-1178.
    PubMed    


  220. MACALUSO FS, Castiglione F, Rispo A, Orlando A, et al
    The VERSIFY Trial: What About Ultrasound Assessment?
    Gastroenterology. 2020;158:1176-1177.
    PubMed    


  221. GAUSMAN V, McNeill MB, Balzora S
    Facing Crohn's: A Rare Association.
    Gastroenterology. 2020;158:829-830.
    PubMed    


  222. APOSTOLOV R, Nicolaides S, Vasudevan A
    Complex Fistulizing Crohn's Disease.
    Gastroenterology. 2020;158:827-828.
    PubMed    


  223. PITTAYANON R, Lau JT, Leontiadis GI, Tse F, et al
    Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.
    Gastroenterology. 2020;158:930-946.
    PubMed     Abstract available


  224. JARDINE S, Anderson S, Babcock S, Leung G, et al
    Drug Screen Identifies Leflunomide for Treatment of Inflammatory Bowel Disease Caused by TTC7A Deficiency.
    Gastroenterology. 2020;158:1000-1015.
    PubMed     Abstract available


    February 2020
  225. SANDBORN WJ, Ghosh S, Panes J, Schreiber S, et al
    Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis.
    Gastroenterology. 2020 Feb 21. pii: S0016-5085(20)30241.
    PubMed     Abstract available


  226. PEREZ-JELDRES T, Alvarez-Lobos M, Nieves JR, Villablanca EJ, et al
    The cell circuitry of ulcerative colitis, a new view for a highly complex disease.
    Gastroenterology. 2020 Feb 14. pii: S0016-5085(20)30228.
    PubMed    


  227. TAKENAKA K, Ohtsuka K, Fujii T, Negi M, et al
    Development and Validation of a Deep Neural Network for Accurate Evaluation of Endoscopic Images From Patients with Ulcerative Colitis.
    Gastroenterology. 2020 Feb 11. pii: S0016-5085(20)30212.
    PubMed     Abstract available


  228. AGRAWAL M, Ungaro RC, Colombel JF
    New Blood Marker of Endoscopic Disease Activity-A Step Forward in Treating Crohn's Disease to Target?
    Gastroenterology. 2020;158:463-465.
    PubMed    


  229. FRITSCH J, Abreu MT
    Exposing the Achilles Heel of Antibiotic Therapy for Pouchitis Using Microbial Function and Composition.
    Gastroenterology. 2020;158:470-472.
    PubMed    


  230. D'HAENS G, Kelly O, Battat R, Silverberg MS, et al
    Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.
    Gastroenterology. 2020;158:515-526.
    PubMed     Abstract available


  231. SONDHI AR, Nayak LJ, Mowers J
    Cachexia, Colitis, and Cancer.
    Gastroenterology. 2020;158:488-490.
    PubMed    


    January 2020
  232. CHIBA M, Tsuji T, Komatsu M
    How to Optimize Effects of Infliximab in Inflammatory Bowel Disease: Incorporation of Plant-based Diet: Infliximab Optimization Needs Dietary Fiber.
    Gastroenterology. 2020 Jan 14. pii: S0016-5085(20)30106.
    PubMed    


  233. FEUERSTEIN JD, Isaacs KL, Schneider Y, Siddique SM, et al
    AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30018.
    PubMed    


  234. HAMMOUDI N, Bondeelle L, Gornet JM
    An unusual case of chronic cough revealing ulcerative colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30083.
    PubMed    


  235. KENNEDY J, Satsangi J, Chapman TP
    Just another flare of ulcerative colitis?
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30094.
    PubMed    


  236. SINGH S, Allegretti JR, Siddique SM, Terdiman JP, et al
    AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30019.
    PubMed     Abstract available


  237. LIM J, Hammami MB, Mahadevan U
    Infliximab Use in a Child with Ulcerative Colitis and Prior in utero Exposure to Infliximab.
    Gastroenterology. 2020 Jan 8. pii: S0016-5085(20)30012.
    PubMed    


  238. KHALILI H, Burke KE, Roelstraete B, Sachs MC, et al
    Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study.
    Gastroenterology. 2020 Jan 8. pii: S0016-5085(20)30008.
    PubMed     Abstract available


  239. PARK SH, Park SH
    Simplified Magnetic Resonance Index of Activity for Crohn's Disease-Let's Try to Kick It Up a Notch.
    Gastroenterology. 2020;158:281-282.
    PubMed    


  240. WILLIET N, Jardin S, Roblin X
    The Simplified Magnetic Resonance Index of Activity (MARIA) for Crohn's Disease Is Strongly Correlated With the MARIA and Clermont Score: An External Validation.
    Gastroenterology. 2020;158:282-283.
    PubMed    


  241. SAZONOVS A, Kennedy NA, Moutsianas L, Heap GA, et al
    HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
    Gastroenterology. 2020;158:189-199.
    PubMed     Abstract available


  242. SEIDELIN JB, Riis LB, Butt RA
    Crohn's Disease With Progressive Renal Impairment.
    Gastroenterology. 2020;158:58-59.
    PubMed    


  243. GORDON IO, Bettenworth D, Bokemeyer A, Srivastava A, et al
    Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review.
    Gastroenterology. 2020;158:137-150.
    PubMed     Abstract available


    December 2019
  244. DANESE S
    New Drugs In The Ulcerative Colitis Pipeline: Prometheus Unbound.
    Gastroenterology. 2019 Dec 17. pii: S0016-5085(19)41924.
    PubMed    


  245. GRIMAUD F, Serrero M, Magalon J
    Adipose-Derived Therapeutic Products for the Management of Refractory Crohn's Fistula.
    Gastroenterology. 2019;157:1690-1691.
    PubMed    


  246. GUO Y, Bai AP
    Plasticity of Th17 Cells Contributes to Crohn's Disease.
    Gastroenterology. 2019;157:1689.
    PubMed    


  247. COOK L, Stahl M, Han X, Nazli A, et al
    Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Gastroenterology. 2019;157:1584-1598.
    PubMed     Abstract available


  248. HARRIS MS, Wichary J, Zadnik M, Reinisch W, et al
    Competition for Clinical Trials in Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1457-1461.
    PubMed    


  249. BITTAR JM, Burton K, Rahnama S
    Verrucous Plaques of the Buttocks, Perineum, and Umbilicus.
    Gastroenterology. 2019;157:1480-1482.
    PubMed    


  250. DEBOURDEAU A, Boivineau L, Iltache S
    The Little Beast That Pretended to Be a Severe Crohn's Disease.
    Gastroenterology. 2019;157:1483-1484.
    PubMed    


    November 2019
  251. VAZIRI H, Anderson JC
    Stool DNA for the Detection of High Grade Dysplasia and Adenocarcinoma in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2019 Nov 20. pii: S0016-5085(19)41584.
    PubMed    


  252. FUKUNAGA S, Kusaba Y, Tsuruta O
    Use of endocytoscopy for ulcerative colitis surveillance: A case study.
    Gastroenterology. 2019 Nov 15. pii: S0016-5085(19)41567.
    PubMed    


  253. SANDBORN WJ, Peyrin-Biroulet L, Zhang J, Chiorean M, et al
    Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients with Ulcerative Colitis.
    Gastroenterology. 2019 Nov 8. pii: S0016-5085(19)41526.
    PubMed     Abstract available


  254. TORRES J
    Prediction of Inflammatory Bowel Disease: A Step Closer?
    Gastroenterology. 2019 Nov 5. pii: S0016-5085(19)41515.
    PubMed    


  255. ALAMEEL T, Al Sulais E
    Ustekinumab and Pregnancy: Continue or Cease Before You Conceive?
    Gastroenterology. 2019;157:1435.
    PubMed    


  256. BERNSTEIN CN
    Reply.
    Gastroenterology. 2019;157:1443-1444.
    PubMed    


  257. MAHADEVAN U, Fisher S, Riley L, Chambers C, et al
    Reply.
    Gastroenterology. 2019;157:1435-1436.
    PubMed    


  258. SHAH SC
    Friend or Foe in Inflammatory Bowel Disease Pathogenesis: Not All Infections Are Equal.
    Gastroenterology. 2019;157:1441-1442.
    PubMed    


  259. ZHU Y, Johnson LA, Rubin JM, Appelman H, et al
    Strain-Photoacoustic Imaging as a Potential Tool for Characterizing Intestinal Fibrosis.
    Gastroenterology. 2019;157:1196-1198.
    PubMed    


  260. KUO WT, Shen L, Zuo L, Shashikanth N, et al
    Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression.
    Gastroenterology. 2019;157:1323-1337.
    PubMed     Abstract available


  261. BAR-YOSEPH H, Pressman S, Blatt A, Gerassy Vainberg S, et al
    Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies.
    Gastroenterology. 2019;157:1338-1351.
    PubMed     Abstract available


  262. GUNTHER C, Ruder B, Stolzer I, Dorner H, et al
    Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1310-1322.
    PubMed     Abstract available


  263. HINDRYCKX P, Jairath V, Zou G, Feagan BG, et al
    Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1233-1244.
    PubMed     Abstract available


  264. ADEN K, Rehman A, Waschina S, Pan WH, et al
    Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1279-1292.
    PubMed     Abstract available


    October 2019
  265. PAPAMICHAEL K, Cheifetz AS
    Is It Prime Time for Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease?
    Gastroenterology. 2019;157:922-924.
    PubMed    


  266. GONCZI L, Bessissow T, Lakatos P
    Ver(s)ifying the Efficacy of Vedolizumab Therapy on Mucosal Healing in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:925-927.
    PubMed    


  267. GERASIMIDIS K, Svolos V, Nichols B, Papadopoulou R, et al
    Reply.
    Gastroenterology. 2019;157:1161-1162.
    PubMed    


  268. PARAMSOTHY S, Kaakoush NO
    Reply.
    Gastroenterology. 2019;157:1165-1166.
    PubMed    


  269. ASHTON JJ, Beattie RM
    Treatment of Active Crohn's Disease With an Ordinary Food-Based Diet That Replicates Exclusive Enteral Nutrition.
    Gastroenterology. 2019;157:1160-1161.
    PubMed    


  270. ALVARADO DM, Chen B, Iticovici M, Thaker AI, et al
    Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota.
    Gastroenterology. 2019;157:1093-1108.
    PubMed     Abstract available


  271. DANESE S, Sandborn WJ, Colombel JF, Vermeire S, et al
    Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Gastroenterology. 2019;157:1007-1018.
    PubMed     Abstract available


  272. LI K, Friedman JR, Chan D, Pollack P, et al
    Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1019-1031.
    PubMed     Abstract available


  273. DULAI PS, Peyrin-Biroulet L, Danese S, Sands BE, et al
    Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1032-1043.
    PubMed     Abstract available


  274. ASSA A, Matar M, Turner D, Broide E, et al
    Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring.
    Gastroenterology. 2019;157:985-996.
    PubMed     Abstract available


  275. LOWENBERG M, Vermeire S, Mostafavi N, Hoentjen F, et al
    Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:997-1006.
    PubMed     Abstract available


    September 2019
  276. COX SR, Lindsay JO, Fromentin S, Stagg AJ, et al
    Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Gastroenterology. 2019 Sep 27. pii: S0016-5085(19)41366.
    PubMed     Abstract available


  277. DE BACKER E, Bode H, Baert F
    New onset diffuse parenchymal lung disease in a 52-year old female with ulcerative colitis.
    Gastroenterology. 2019 Sep 24. pii: S0016-5085(19)41353.
    PubMed    


  278. XIAO L, Li XX, Chung HK, Kalakonda S, et al
    RNA-Binding Protein HuR Regulates Paneth Cell Function by Altering Membrane Localization of TLR2 via Post-transcriptional Control of CNPY3.
    Gastroenterology. 2019;157:731-743.
    PubMed     Abstract available


  279. PIOVANI D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, et al
    Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses.
    Gastroenterology. 2019;157:647-659.
    PubMed     Abstract available


    June 2019
  280. CHEN JCY, Halawi H, Loftus CG
    New Ascites and Omental Thickening in Ulcerative Colitis.
    Gastroenterology. 2019 Jun 14. pii: S0016-5085(19)41014.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: